EXPO
Exponent, Inc. · Industrials · Engineering & Construction
Last
$68.04
−$0.08 (−0.12%) 4:00 PM ET
Prev close $68.12
Open $69.12
Day high $69.55
Day low $67.14
Volume 867,384
Avg vol 496,112
Mkt cap
$3.36B
P/E ratio
32.71
FY Revenue
$582.01M
EPS
2.08
Gross Margin
100.00%
Sector
Industrials
AI report sections
EXPO
Exponent, Inc.
No AI report section text found yet for this symbol.
Volume vs average
Intraday (cumulative)
+141% (Above avg)
Vol/Avg: 2.41×
RSI
53.89 (Neutral)
Neutral (40–60)
MACD momentum
Intraday
+0.04 (Strong)
MACD: 0.01 Signal: -0.03
Short-Term
+0.51 (Strong)
MACD: -0.37 Signal: -0.88
Long-Term
+0.40 (Strong)
MACD: -1.70 Signal: -2.09
Intraday trend score 57.00

Latest news

EXPO 12 articles Positive: 3 Neutral: 1 Negative: 1
Positive GlobeNewswire Inc. • Na
Exponent Elevates John Pye to President and Eric Anderson to CFO Reporting to Catherine Corrigan, CEO; Rich Schlenker to Remain as Executive VP and to Stand for Election to Board of Directors

Exponent, Inc. announced executive leadership changes effective May 1, 2026, promoting John Pye to President and Eric Anderson to Chief Financial Officer, both reporting to CEO Catherine Corrigan. Richard Schlenker will transition from CFO to Executive Vice President and stand for Board election. Paul Johnston will retire from the Board, with Karen Richardson becoming Chairman at the June 4, 2026 Annual Meeting.

EXPO executive leadership promotion President Chief Financial Officer Board of Directors organizational restructuring
Sentiment note

The announcement reflects strong internal talent development with promotions of experienced executives who have deep institutional knowledge and proven track records. The leadership transitions are orderly and well-planned, with continuity maintained through experienced leaders. The company also increased its quarterly dividend from $0.30 to $0.31 per share, signaling financial strength and confidence in future performance.

Positive Benzinga • Globe Newswire
Exponent Reports Fourth Quarter and Fiscal Year 2025 Financial Results

Exponent (NASDAQ: EXPO) reported strong Q4 2025 results with total revenues increasing 7.8% to $147.4 million and net income rising to $24.8 million ($0.49 per diluted share). For fiscal year 2025, revenues grew 4.2% to $582.0 million with net income of $106.0 million ($2.07 per diluted share). The company increased its quarterly dividend from $0.30 to $0.31 and provided guidance for FY2026 expecting high-single-digit revenue growth with EBITDA margins of 27.6% to 28.1%.

EXPO financial results revenue growth earnings dividend increase guidance EBITDA engineering services
Sentiment note

Strong Q4 and FY2025 results with revenue growth of 7.8% in Q4 and 4.2% for the full year, improved net income, increased EBITDA margins, dividend increase, and positive forward guidance for FY2026 with expected high-single-digit revenue growth. Management expressed confidence in market opportunities and long-term growth trajectory.

Positive Benzinga • Globe Newswire
Exponent Increases Quarterly Dividend Payment from $0.30 to $0.31 per Share for Q1 2026

Exponent Inc. (NASDAQ: EXPO) announced that its Board of Directors has increased its quarterly cash dividend from $0.30 to $0.31 per share, effective for Q1 2026. The dividend will be paid on March 20, 2026 to shareholders of record as of March 6, 2026. CEO Dr. Catherine Corrigan attributed the increase to strong market drivers and confidence in the company's scientific and engineering capabilities.

EXPO dividend increase quarterly dividend shareholder returns capital allocation Exponent Inc consulting services
Sentiment note

The company increased its quarterly dividend by approximately 3.3% (from $0.30 to $0.31), demonstrating confidence in future cash flows and commitment to returning capital to shareholders. The CEO's commentary about strong market drivers and confidence in the business further supports a positive outlook.

Negative The Motley Fool • Jake Lerch
Independent Investment Manager Sells $24.6 Million of Exponent Stock, According to Recent Filing

Conestoga Capital Advisors sold 344,631 shares of Exponent, valued at $24.63 million, reducing its stake from 2.99% to 2.63% of its portfolio in Q3 2025. The sale comes amid Exponent's underperformance compared to the S&P 500.

EXPO DSGX FSV stock sale investment management consulting services market performance
Sentiment note

Stock has underperformed S&P 500 by over 50 percentage points year-to-date, and the investment manager reduced its position, indicating reduced confidence in the company's near-term prospects

Neutral The Motley Fool • Jesterai
Exponent (EXPO) Q2 Revenue Rises 1%

Exponent reported a modest 1% revenue increase to $142.0 million in Q2 FY2025, with declining profitability due to rising operating costs. The company saw stable performance driven by reactive consulting services, particularly in construction and medical devices, while experiencing softness in proactive services.

EXPO consulting engineering financial results revenue profitability
Sentiment note

Mixed financial performance with slight revenue growth (1%) but declining profitability (EPS down 8.8%), stable reactive services, but weakness in proactive segments

Unknown Zacks Investment Research • Zacks Equity Research
Is Exponent (EXPO) Outperforming Other Business Services Stocks This Year?

Here is how Exponent (EXPO) and Nu Holdings Ltd. (NU) have performed compared to their sector so far this year.

EXPO NU
Unknown Zacks Investment Research • Zacks Equity Research
Are Business Services Stocks Lagging Exponent (EXPO) This Year?

Here is how Exponent (EXPO) and Nu Holdings Ltd. (NU) have performed compared to their sector so far this year.

EXPO NU
Unknown Zacks Investment Research • Zacks Equity Research
Exponent (EXPO) Just Flashed Golden Cross Signal: Do You Buy?

Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?

EXPO
Unknown Zacks Investment Research • Zacks Equity Research
Is HNI (HNI) Stock Outpacing Its Business Services Peers This Year?

Here is how HNI (HNI) and Exponent (EXPO) have performed compared to their sector so far this year.

EXPO
Unknown Zacks Investment Research • Zacks Equity Research
Why Exponent (EXPO) Might be Well Poised for a Surge

Exponent (EXPO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

EXPO
Unknown Zacks Investment Research • Zacks Equity Research
Exponent (EXPO) Surpasses Q1 Earnings and Revenue Estimates

Exponent (EXPO) delivered earnings and revenue surprises of 28.26% and 9.25%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

EXPO III
Unknown GlobeNewswire Inc. • Exponent, Inc.
Exponent Declares Regular Quarterly Dividend for Q2 2024

MENLO PARK, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.28 per share of common stock to be paid on June 21, 2024 to all common stockholders of record as of June 7, 2024.

EXPO Dividend Reports and Estimates
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal